Frank A. Scappaticci
Frank A. Scappaticci, MD, PhD is a clinical oncologist and hematologist working at Genentech / Roche. Dr. Scappaticci obtained his undergraduate degree at Yale University in biochemistry. Subsequently, he trained at the University at Buffalo / Roswell Park where he obtained his medical and graduate degrees. He completed his internship and residency in Internal Medicine at the University of Pennsylvania. Following this, he obtained his Medical Center. After a short period on faculty at Stanford and the University of California / Davis he joined Genentech approximately 9 years ago and has been working on late stage clinical trial development for Avastin. He had led numerous filings for Avastin that eventually led to approval for Avastin in colorectal, non-small cell lung, and renal cancers. Recently, Dr. Scappaticci was appointed as the clinical science leader on the Roche Biologics Task force.